Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.50
Bid: 14.25
Ask: 14.75
Change: 1.625 (12.62%)
Spread: 0.50 (3.51%)
Open: 12.90
High: 14.625
Low: 12.75
Yest. Close: 12.875
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

IN BRIEF: Seneca Growth Profits From Scancell, Omega Share Sales

IN BRIEF: Seneca Growth Profits From Scancell, Omega Share Sales

16 Sep 20 22:16

Scancell Consortium Gets Innovate UK Funding For Covid Vaccine Trial

Scancell Consortium Gets Innovate UK Funding For Covid Vaccine Trial

27 Aug 20 11:16

Scancell Raises GBP15 Million To Fund Covid-19 Vaccine Development

Scancell Raises GBP15 Million To Fund Covid-19 Vaccine Development

11 Aug 20 16:18

IN BRIEF: Scancell Secures GBP2 Million From Placing

IN BRIEF: Scancell Secures GBP2 Million From Placing

22 Jul 20 20:43

IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue

IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue

22 Jul 20 11:24

Scancell To Start Clinical Trial For Cancer Treatment In 2021

Scancell To Start Clinical Trial For Cancer Treatment In 2021

24 Jun 20 12:18

Scancell upbeat on publication of AvidiMab research

(Sharecast News) - Cancer immunotherapy developer Scancell Holdings noted the publication of its manuscript in Cancer Research, a journal of the American Association of Cancer Research (AACR) on Friday, titled 'Engineering the human Fc-region enables direct cell killing by cancer glycan-targeting antibodies without the need for immune effector cells or complement'.

12 Jun 20 12:59

Director dealings: Scancell director lowers stake

(Sharecast News) - Scancell revealed on Tuesday that non-executive director Martin Diggle had sold 1.5m ordinary shares in the AIM-listed biotechnology firm.

28 Apr 20 16:40

UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price

UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price

28 Apr 20 14:43

Scancell Rises On Launch Of Covid-19 Vaccine Research Programme

Scancell Rises On Launch Of Covid-19 Vaccine Research Programme

24 Apr 20 12:00

UK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost

UK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost

24 Apr 20 10:49

Scancell's 'SCIB1' clears latest regulatory hurdle in US

(Sharecast News) - Cancer immunotherapy developer Scancell announced on Monday that its investigational new drug (IND) application to the United States Food and Drug Administration (FDA) for 'SCIB1' has been approved.

3 Feb 20 14:20

Scancell Gets US FDA Approval For SCIB1 Drug Application

Scancell Gets US FDA Approval For SCIB1 Drug Application

3 Feb 20 10:44

Scancell Interim Loss Narrows, Progresses On Product Pipeline

Scancell Interim Loss Narrows, Progresses On Product Pipeline

31 Jan 20 11:12

Scancell Teams To Evaluate Its Antibody Platform For Cancer Treatment

Scancell Teams To Evaluate Its Antibody Platform For Cancer Treatment

20 Jan 20 12:04

Login to your account

Don't have an account? Click here to register.